Dow Spin-Off Pfenex Inks Licensing Pact With Merck For Its Protein Technology
The big drug maker will pay as much as $52 million to tap protein expression technology used to make proteins for developing a vaccine candidate.
The big drug maker will pay as much as $52 million to tap protein expression technology used to make proteins for developing a vaccine candidate.